Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark)

NCT00340574 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Healthy Volunteer
HV

Interventions

DRUG: AMA1-C1/Alhydrogel + CpG 7909

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)